2020
DOI: 10.3390/diagnostics10050303
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers for Temporomandibular Disorders: Current Status and Future Directions

Abstract: Numerous studies have been conducted in the previous years with an objective to determine the ideal biomarker or set of biomarkers in temporomandibular disorders (TMDs). It was recorded that tumour necrosis factor (TNF), interleukin 8 (IL-8), IL-6, and IL-1 were the most common biomarkers of TMDs. As of recently, although the research on TMDs biomarkers still aims to find more diagnostic agents, no recent study employs the biomarker as a targeting point of pharmacotherapy to suppress the inflammatory responses… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 121 publications
0
8
0
1
Order By: Relevance
“…Interestingly, IL-6 level at the synovial fluid has been widely associated with TMD ( 171 ). IL-6 level is undetectable in synovial fluid from healthy controls ( 172 , 173 ), but it is increased in that from patients with chronic TMD ( 174 ).…”
Section: Masticatory Muscles and Bones As Secretory Tissues Muscle-bmentioning
confidence: 99%
“…Interestingly, IL-6 level at the synovial fluid has been widely associated with TMD ( 171 ). IL-6 level is undetectable in synovial fluid from healthy controls ( 172 , 173 ), but it is increased in that from patients with chronic TMD ( 174 ).…”
Section: Masticatory Muscles and Bones As Secretory Tissues Muscle-bmentioning
confidence: 99%
“…Researchers have also classified the pain biomarkers based on the method of acquisition such as direct physiological measures, bio samples, genetic testing, and imaging. 19 21 …”
Section: Introductionmentioning
confidence: 99%
“…The role of biomarkers for the diagnosis of oral cancers, temporomandibular joint disorders (TMD), periodontal disease, and caries have been actively investigated (17)(18)(19). Tumor necrosis factor (TNF) and TNF receptor (TNFR) 2 have been identified as biomarkers for diagnosis as well as treatment in terms of reduction of inflammation and pain of TMD (20). Salivary microRNAs have been studied as possible diagnostic and prognostic biomarkers for oral cancers and periodontal disease (18).…”
Section: Role Of Biomarkers In Oral Diseasesmentioning
confidence: 99%